About Eat Just
Eat Just develops plant-based alternatives to eggs, mayonnaise, and meat. Good Meat, a division of Eat Just, offers meat made from animal cells instead of livestock. The company was formerly known as Hampton Creek. It was founded in 2011 and is based in Alameda, California.
Missing: Eat Just's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Eat Just's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Eat Just
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Eat Just in 4 CB Insights research briefs, most recently on Aug 9, 2021.
Expert Collections containing Eat Just
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eat Just is included in 5 Expert Collections, including Agriculture Technology (Agtech).
Agriculture Technology (Agtech)
Companies that are using technology to make farms more efficient.
Unicorns- Billion Dollar Startups
Food & Beverage
This Collection includes B2B and B2C companies developing alternatives to animal-derived proteins, including plant-based meat, dairy alternatives, lab-grown or cultured meat, and fermented proteins.
We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.
Eat Just Patents
Eat Just has filed 35 patents.
Robotics, Military robots, Robotic submarines, Robots, Animal welfare
Robotics, Military robots, Robotic submarines, Robots, Animal welfare
Latest Eat Just News
Jan 18, 2023
I cover exclusive financial news of the food & beverage industry. Got it! Got it! Got it! Eat Just Inc. Global food tech company Eat Just Inc.’s cell-cultured meat division, Good Meat, will significantly scale up production after its serum-free media gained regulatory approval by the Singapore Food Agency (SFA), on track to reach price parity with conventional meat by 2027. Serum, or in layman’s terms, the fluid component of blood, is traditionally used in bioreactors to cultivate animal cells until they differentiate into the skeletal muscle, fat, and connective tissues, yet removing it from production to achieve better cost efficiency has been a major technical hurdle for cultured meat manufacturers, according to Josh Tetrick, CEO of Eat Just. “It’s more cost effective to use amino acids, sugar and salt without any serum,” Tetrick recently said during an exclusive interview, “and we can produce more meat at scale.” What Qualifies ‘Scale’ In Cultured Meat Production? Cultured meat has become a hot-button topic since Dutch pharmacologist, Mark Post, unveiled the world’s first cell-based vitro burger in 2013. On one hand, believers argue it could be an advanced solution to restoring biodiversity, while dramatically reducing carbon emissions from traditional animal farming; naysayers claim scalability will remain a long-term challenge since building vessels, the bioreactor for growing cells, is expensive and it demands significant amount of electricity, coupled with mixed consumer feedback on the actual flavor, texture, and nutrition of the product. “When we talk about ‘scale,’ we’re talking about 40-plus million pounds, sufficient to achieve national distribution across the U.S.,” Tetrick explained, which is why Good Meat is installing larger vessels in a new facility to keep up with its future demand. MORE FOR YOU The facility, supported by an investment of over $100 million, will house what Good Meat claims to be the single-largest bioreactor in the cultivated meat industry to date: a 6,000-liter vessel built in partnership with bioreactor technology company ABEC, Inc. The plant, which will be running the company’s serum-free formulation process, is slated to open in later 2023. A key determinant for manufacturing capacity is cell density — more stem cells a vessel contains, more meat can be produced during the given period of time. Good Meat’s main competitor, Israel-headquartered Believer Meats, recently claimed to have achieved a production density of 100 billion cells per liter. That, coupled with their medium that costs less than $5 per liter, cuts average projected costs of cultivated meat three-fold, the company’s founder, Professor Yaakov Nahmias, was quoted saying. Good Meat will drive their serum-free media cost further down from the current $1 per liter to “tens of cents,” according to Tetrick, allowing the company to produce “hundreds of thousands of pounds” of cultivated meat. “Our next phase is to install vessels north of 100,000 liter each, which will enable tens of millions of pounds,” he told me, “but that won’t be up and ready until late 2024.” Eat Just Inc. expects to sell its Good Meat products in the U.S. in 2023 after receiving regulatory ... [+] approval. Eat Just Inc. Since Singapore became the first country in the world to allow the commercial sale of cultivated meat in 2020, Good Meat has started selling its chicken nuggets and breasts across local fine dining restaurants and street food vendors. It also recently teamed up with family-owned Huber's Butchery, where dishes such as Good Meat cultivated chicken salad with cilantro lime dressing, are selling around SG$18.5, about $14. “We lose money when we sell, but we're also not selling a lot,” Tetrick said, “so it's not like we're burning a lot of cash.” Little Regulatory Hurdles Remain In The U.S. Removing serum is only the first step to reduce manufacturing cost for cell meat, and the growth factors used to replace the commonly used fetal bovine serum can be equally expensive, according to Joshua March, CEO of California-based SCiFi Foods . “We are skeptical that the cost of producing growth factors can be reduced significantly enough for cultivated meat to get to cost parity with conventional meat, at least in the near term,” March wrote me via email. “Instead, we are using CRISPR [a non-GMO process] to engineer our cell lines to grow without the need for added growth factors, dramatically reducing the cost of cell culture media.” Already growing cells in a serum-free bioreactor process, SCiFi Foods is in the process of getting its 500-liter pilot plant operational, and is aiming for 10 million cells/ml and a cost of $10 per burger by the end of this year. In the U.S., where the FDA and the USDA co-established an agreement in 2019 to divide oversight authority for the cultured meat sector, Upside Foods, which is backed by Bill Gates, and valued at more than $1 billion, is the only company so far that has passed the FDA pre-market consultation process. The next steps for the San Francisco-based company are to work with the USDA on labeling and inspection. Uma Valeti, Upside Foods’ CEO, said: “We have multiple serum-free media formulations for our products. We also have certain products which require a small amount of animal components, which we will be removing as we advance. “Our production capacity at EPIC (Engineering, production and innovation center) is up to 50,000 pounds of cultivated chicken products annually. We also designed this facility for innovation and engineering, so we will be using its capacity flexibly as needed to advance our core technologies.” As little regulatory hurdles remain ahead, manufacturers unanimously anticipate cultured meat to finally become available on American consumers’ plates this year. “We will be selling [in the U.S.] in 2023,” Tetrick said. “We’re going to start with internationally acclaimed chef José Andrés’ restaurants, and then enter channels similar to what we’ve done in Singapore.”
Eat Just Frequently Asked Questions (FAQ)
When was Eat Just founded?
Eat Just was founded in 2011.
Where is Eat Just's headquarters?
Eat Just's headquarters is located at 300 Wind River Way, Alameda.
What is Eat Just's latest funding round?
Eat Just's latest funding round is Private Equity.
How much did Eat Just raise?
Eat Just raised a total of $731.6M.
Who are the investors of Eat Just?
Investors of Eat Just include C2 Capital Partners, UBS O'Connor, Graphene Ventures, AIV Capital, Resilience Capital Partners and 32 more.
Who are Eat Just's competitors?
Competitors of Eat Just include Prime Roots, Back to Nature, THIS, UPSIDE Foods, The EVERY Company , Impossible Foods, The Abbot's Butcher, New Age Meats, Growthwell, Alpha Foods and 13 more.
Compare Eat Just to Competitors
Impossible Foods develops technologies to produce plant-based foods that replace existing meat and dairy products in taste and nutrition, at a lower cost and with a much lower impact on the global environment. Impossible Chicken Nuggets are made with soy protein to deliver a meaty bite.
Prime Roots uses plant-based products as an alternative protein that replicates the taste, texture, and nutrition of meat and seafood products. Products are made from Koji, which is a Japanese superfood that is high protein super protein. The company was founded in 2017 and is based in Berkeley, California.
SuperMeat is a food-tech company developing meat grown directly from animal cells. The company's products offer a delicious meat experience and a high-quality, nutritional profile that is manufactured in a sustainable, slaughter-free way. It is a B2B company that addresses the entire category of poultry meat from fat to muscle, providing a complete solution to cultivated meat production. SuperMeat was founded in 2015 and is based in Tel Aviv, Israel.
The Abbot's Butcher makes artisan plant-based meats.
Aleph Farms is a food-tech firm specializing in high-quality, sustainable, and cell-grown meat. Aleph's 3D technology uses the four core cell types of farmed beef to recreate a real food experience. It was founded in 2017 and is based in Rehovot, Israel.
Modern Meadow is focused on biologically advanced materials. The company harnesses the power of design, biology, and materials science to produce biofabricated materials that are animal-free and incur less harm to the environment. Modern Meadow materials enable new design, performance possibilities and partners with consumer brands.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.